OHR Pharmaceutical Inc (NASDAQ:OHRP) shares traded down 5.3% during trading on Thursday . The stock traded as low as $0.17 and last traded at $0.18. 607,443 shares were traded during trading, a decline of 50% from the average session volume of 1,206,177 shares. The stock had previously closed at $0.19.

Separately, ValuEngine raised OHR Pharmaceutical from a “hold” rating to a “buy” rating in a research note on Thursday, November 1st.

OHR Pharmaceutical (NASDAQ:OHRP) last released its earnings results on Tuesday, August 14th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter.

ILLEGAL ACTIVITY NOTICE: “OHR Pharmaceutical (OHRP) Trading Down 5.3%” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.thecerbatgem.com/2018/11/15/ohr-pharmaceutical-ohrp-trading-down-5-3.html.

OHR Pharmaceutical Company Profile (NASDAQ:OHRP)

OHR Pharmaceutical, Inc, a clinical-stage pharmaceutical company, focuses on the development of novel therapies for the treatment of ophthalmic diseases. Its lead clinical program is topical Squalamine, a small molecule anti-angiogenic drug, which could provide a non-invasive therapy to enhance vision outcomes.

Further Reading: Stop Order

Receive News & Ratings for OHR Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OHR Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.